Emmessar Biotech & Nutrition Ltd Share Price (524768)
as on
| Source : BSE
Emmessar Biotech & Nutrition Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹27.31₹29.34
5.47%
Downside
1.56%
Upside
52 Week's Low
52 Week's High
₹27₹646.54%
Downside
121.53%
Upside
| Market Stats | |
| Previous Close | ₹28.67 |
| Open | ₹29.34 |
| Volume | 572.00 |
| Upper Circuit | ₹30.10 |
| Lower Circuit | ₹27.24 |
| Day's Low | ₹27.31 |
| Day's High | ₹29.34 |
| 52 Week Low | ₹27 |
| 52 Week High | ₹64 |
| Returns % | |
| 1 Month Return | -11.87 % |
| 3 Month Return | -17.92 % |
| 1 Year Return | -29.94 % |
| 3 Year Return | + 15.84 % |
| 5 Year Return | + 91.26 % |
Emmessar Biotech & Nutrition Ltd Stock Fundamentals & Key Indicators
Check Emmessar Biotech & Nutrition Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹14.34 Cr
Return on Equity (ROE)
10.65
PE Ratio (TTM)
0Return on capital employed (ROCE)
10.31
Beta (LTM)
0.84
P/B Ratio
2.01
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
88.89
EPS (TTM)
0Sector
Chemicals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Emmessar Biotech & Nutrition Ltd Stock's Interest Amongst Investors
Emmessar Biotech & Nutrition Ltd Financial Results
Get the annual and quarterly financial summary of Emmessar Biotech & Nutrition Ltd, including revenue, profit, loss and more.
Emmessar Biotech & Nutrition Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Ltd Earnings Results
Emmessar Biotech & Nutrition Ltd’s net profit jumped 88.89% since last year same period to ₹0.17Cr in the Q1 2025-2026. On a quarterly growth basis, Emmessar Biotech & Nutrition Ltd has generated 342.86% jump in its net profits since last 3-months.
Read More about Earnings Results
Emmessar Biotech & Nutrition Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Emmessar Biotech & Nutrition Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.53% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0.05% | 0.00 | |
| Retail Investors | 40.28% | 0.00 | |
| Others | 0.14% | 0.00 |
Emmessar Biotech & Nutrition Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Emmessar Biotech & Nutrition Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 14.34 | 18.25% | 0.00 | 1 | 1 | |
| NA | 274.90 | 7.76% | 0.81 | 4 | 186 | |
| NA | 56.18 | 10.3% | 0.77 | -5 | 50 | |
| NA | 4,117.69 | 16.19% | 0.62 | 87 | 1,561 | |
| NA | 73.16 | 16.9% | 0.52 | 2 | 37 |
Emmessar Biotech & Nutrition Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Emmessar Biotech & Nutrition Ltd.
Emmessar Biotec Reports Growth in Sales and EBITDA - 25 Apr, 2025
Emmessar Biotec's standalone net sales for March 2025 reached Rs 0.10 crore, up 27.09% YoY. EBITDA increased by 211.11% to Rs 0.28 crore, while net loss decreased significantly. However, shares have declined 8.01% over the last six months.
Insights on Emmessar Biotech & Nutrition Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 59.53% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 52.7%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 40.28% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 123.1%
NEGATIVE IMPACTPrice Dip
In the last 1 month, Emmessar Biotech stock has moved down by -11.9%
About Emmessar Biotech & Nutrition Ltd
Revenue: ₹0.09Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.17Cr as on June 2025 (Q1 FY26)
Chairperson Name: MSR Ayyangar
| Organisation | Emmessar Biotech & Nutrition Ltd |
| Industry | Chemicals |
| CEO | MSR Ayyangar |
| E-voting on shares | Click here to vote |
FAQs
What is Emmessar Biotech & Nutrition Ltd share price today?
Emmessar Biotech & Nutrition Ltd share price today stands at ₹28.89, Open: ₹29.34, Previous Close: ₹28.67, High: ₹29.34, Low: ₹27.31, 52 Week High: ₹64, 52 Week Low: ₹27 as on .
How to buy Emmessar Biotech & Nutrition Ltd shares ?
To buy Emmessar Biotech & Nutrition Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 524768 or Emmessar Biotech & Nutrition Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Emmessar Biotech & Nutrition Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Emmessar Biotech & Nutrition Ltd?
Today's traded volume of Emmessar Biotech & Nutrition Ltd is 572.00. Which means that 572.00 shares of Emmessar Biotech & Nutrition Ltd were bought and sold on the stock market during today's trading session.
What is Emmessar Biotech & Nutrition Ltd's market cap today?
Today's market capitalisation of Emmessar Biotech & Nutrition Ltd is ₹14.34 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Emmessar Biotech & Nutrition Ltd?
Emmessar Biotech & Nutrition Ltd’s 52 week high is ₹64 and 52 week low is ₹27. The current share price of Emmessar Biotech & Nutrition Ltd is ₹28.89, which is -54.86% down from its 52 week high and 7.00% up from its 52 week low.